HALO fund manager activity
Halozyme Therapeutics, Inc · Nasdaq. Reported by 7 tracked fund managers in their 13F filings, Q4 2013 to Q2 2026.
Q2 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 381,745 | $19,858,378 | 0.01% | Aug 13, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 68,052 | $3,540,065 | 0.02% | Aug 14, 2025 |
| Torray Funds | Trimmed | 40,048 | $2,083,297 | 0.30% | Aug 5, 2025 |
Q1 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Added | 417,516 | $26,641,700 | 0.01% | May 14, 2025 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 32,531 | $2,075,803 | 0.02% | May 15, 2025 |
| Torray Funds | Trimmed | 55,384 | $3,534,053 | 0.53% | May 8, 2025 |
Newer quarters · Older quarters